Navigating the procurement of specialized bioregulatory peptides requires strict verification of compound identity, purity, and endotoxin parameters. PX1 Research provides laboratory-grade Cortagen (Ala-Glu-Asp-Pro) manufactured in US-based, GMP-compliant facilities for advanced epigenetic and cellular research.
Navigating the procurement of specialized bioregulatory peptides requires strict verification of compound identity, purity, and endotoxin parameters. PX1 Research provides laboratory-grade Cortagen (Ala-Glu-Asp-Pro) manufactured in US-based, GMP-compliant facilities for advanced epigenetic and cellular research.
When seeking a reliable supplier to buy Cortagen for heterochromatin regulation research, laboratory investigators require high-purity, USA-manufactured peptides supported by lot-specific analytical verification. Cortagen (Ala-Glu-Asp-Pro) is a synthetic tetrapeptide studied for its capacity to modulate gene expression through heterochromatin decondensation in aging or damaged neuronal tissues, available exclusively for laboratory research use from PX1 Research.
Epigenetic regulation through chromatin structural alteration represents a critical focus in contemporary molecular biology. Research groups investigating how short peptide sequences penetrate nuclear membranes and interact with genomic structure demand absolute consistency in sequence fidelity. Obtaining Cortagen from verified sources ensures that cellular assays evaluate the authentic tetrapeptide without background noise caused by synthesis artifacts, truncated sequences, or bacterial endotoxins.
Cortagen is a synthetic short-chain peptide composed of four amino acid residues: L-alanyl-L-glutamyl-L-aspartyl-L-proline (sequence: H-Ala-Glu-Asp-Pro-OH). It belongs to the class of short bio-regulatory peptides initially conceptualized to mimic endogenous tissue-specific signaling molecules. With a precise molecular mass of approximately 430.42 g/mol, its minimal steric bulk permits distinct conformational interactions within biological matrices.
In cell-free and cellular models, the acidic residue profile (glutamic acid and aspartic acid paired with alanine and proline) gives Cortagen a net negative charge at physiological pH. This unique electrostatic signature is hypothesized to facilitate selective non-covalent interactions with histone proteins and specific nucleotide sequences in regions of condensed heterochromatin. Qualified investigators sourcing this compound can explore detailed specifications through our comprehensive research peptides catalog.
Heterochromatin represents the tightly packed, transcriptionally silent form of DNA within the eukaryotic cell nucleus. As cells undergo senescent transitions or experience oxidative insult, heterochromatin density changes, often resulting in widespread silencing of essential protective genes or aberrant reactivation of repetitive elements. Preclinical studies suggest that short regulatory peptides like Cortagen can alter chromatin conformation, promoting a transition from densely packed heterochromatin to open, transcriptionally active euchromatin.
In vitro models suggest that Cortagen interacts with the promoter regions of genes controlling cellular repair, neurogenesis, and anti-inflammatory signaling cascades. By binding directly to histone tails or altering DNA methylation patterns, the peptide appears to induce local decondensation of heterochromatin. This localized structural relaxation enables RNA polymerase complexes and transcription factors to access previously masked DNA sequences, serving as a primary model for studying targeted gene reactivation without permanent genomic modifications.
Laboratory investigations employing rodent models of cerebral ischemia, peripheral nerve injury, and age-related neurodegeneration have demonstrated that Cortagen administration influences gene expression profiles associated with structural restoration. In vitro assays using primary neuronal cultures indicate that exposure to Cortagen reduces rates of apoptosis following excitotoxic or oxidative stress.
Furthermore, preclinical literature demonstrates that Cortagen modulates the expression of inflammatory cytokines, notably downregulating pro-inflammatory markers such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) while upregulating neurotrophic factors. Researchers tracking structural genomic changes report that these transcriptional shifts correspond directly with measurable reductions in heterochromatin markers within targeted cell nuclei. Further analysis of peptide-driven genetic mechanisms can be explored across our research library hub.
Cortagen belongs to a broader family of short regulatory peptides studied for tissue-specific gene regulation. To understand its distinct biochemical profile, investigators frequently compare Cortagen (Ala-Glu-Asp-Pro) against related synthetic constructs such as Epitalon (Ala-Glu-Asp-Gly), Pinealon (Glu-Asp-Arg), and Vilon (Lys-Glu).
While Epitalon is primarily evaluated for its role in telomerase expression and pineal gland regulation, Cortagen exhibits a targeted affinity for central nervous system gene expression and neuronal heterochromatin remodeling. The single amino acid replacement at the C-terminus—proline in Cortagen versus glycine in Epitalon—alters the peptide's conformational flexibility, directing its nuclear interaction profile toward cortical and hippocampal cell lines. A deeper examination of these structural variations is detailed in our overview of Khavinson peptide mechanisms.
For research findings to be reproducible, peptide compounds must undergo rigorous analytical characterization prior to experimental deployment. PX1 Research subjects every synthesis lot of Cortagen to comprehensive dual-testing protocols, performed within independent, ISO 17025 accredited laboratories located in the United States.
Purity is quantified using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring that target peptide concentration exceeds 98.0%, with residual trifluoroacetate (TFA) salts minimized to avoid cell culture toxicity. Compound identity is simultaneously verified using Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF), confirming exact molecular weight without cross-contaminant synthetic side-products. Every shipment includes full batch documentation accessible for analytical review.
Bacterial endotoxins (lipopolysaccharides or LPS) represent a major confounding variable in cellular biology and heterochromatin research. Elevated endotoxin presence in peptide samples can independently activate Toll-like receptor pathways (TLR4), triggering downstream inflammatory cascades and altering nuclear architecture. Such artifacts corrupt experimental data when evaluating peptide-specific epigenetic effects.
PX1 Research enforces strict endotoxin screening protocols using Chromogenic Limulus Amebocyte Lysate (LAL) assays. All Cortagen lots intended for laboratory research must demonstrate endotoxin levels significantly below established industry thresholds (<0.01 EU/mg). This stringent limit guarantees that observed changes in heterochromatin structure or gene transcription stem purely from the experimental compound, preserving assay validity.
To maintain structural stability, Cortagen is supplied as a lyophilized (freeze-dried) powder packaged in sealed, sterile glass vials under inert gas. Upon receipt, un-reconstituted vials should be stored at -20°C for short-term preservation or -80°C for long-term storage, protected from light and moisture ingress.
Reconstitution should be performed under sterile laminar flow conditions using sterile laboratory-grade water or phosphate-buffered saline (PBS, pH 7.4). Gentle agitation is recommended to bring the peptide into complete solution; high-shear vortexing or sonicating should be avoided to prevent mechanical cleavage. Once reconstituted, liquid stock solutions should be aliquoted into single-use microcentrifuge tubes and maintained at -80°C to eliminate damage caused by repeated freeze-thaw cycles.
PX1 Research operates as a dedicated USA supplier tailored to academic institutions, private biotechnology laboratories, and contract research organizations (CROs). Operating out of advanced manufacturing and fulfillment facilities in California and Arizona, PX1 guarantees rapid processing, reliable batch consistency, and transparent supply chain logistics.
Whether procuring small quantities for preliminary screening or establishing dedicated supply channels for high-throughput assays, qualified institutions can establish custom procurement parameters. Explore institutional purchasing options directly through our wholesale lab accounts hub to access bulk inventory, dedicated technical support, and lot-reserved ordering.
What is Cortagen and how is it used in heterochromatin research?
Cortagen (Ala-Glu-Asp-Pro) is a synthetic tetrapeptide evaluated in laboratory settings for its ability to induce heterochromatin decondensation, facilitating gene transcription and expression in neuronal cell models.
How does PX1 Research verify the purity of Cortagen?
Every lot of Cortagen undergoes third-party verification using RP-HPLC to confirm purity (>98%) and mass spectrometry (ESI-MS or MALDI-TOF) to verify exact molecular weight.
What is the primary structural difference between Cortagen and Epitalon?
Cortagen possesses a C-terminal proline residue (Ala-Glu-Asp-Pro), whereas Epitalon features a C-terminal glycine (Ala-Glu-Asp-Gly). This structural variation alters target binding specificity in tissue models.
What endotoxin levels are acceptable for Cortagen in research assays?
PX1 Research enforces an endotoxin limit of <0.01 EU/mg verified via LAL assay, preventing false-positive TLR4 activation during cell culture experiments.
How should lyophilized Cortagen be stored upon arrival?
Lyophilized Cortagen should be kept at -20°C for short-term storage or -80°C for extended preservation, protected from light exposure and humidity.
Can Cortagen solutions undergo multiple freeze-thaw cycles?
No. Repeated freeze-thaw cycles can degrade peptide bonds. Reconstituted Cortagen should be divided into single-use aliquots and frozen at -80°C.
Is Cortagen supplied by PX1 Research approved for human therapeutic use?
No. All compounds provided by PX1 Research are strictly intended for laboratory in vitro and preclinical research applications and are not for human or veterinary use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.